Compounds > arsenic trioxide
Page last updated: 2024-08-21

arsenic trioxide and folic acid

arsenic trioxide has been researched along with folic acid in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Das, AS; Karmakar, S; Maiti, A; Majumdar, S; Mitra, C; Mukherjee, M; Mukherjee, S; Nanda, A1
Ahn, R; Chen, H; O'Halloran, TV; Thompson, DH; Van den Bossche, J1
Althuri, A; Banerjee, R; Binod, P; Mathew, J; Pandey, A; Sindhu, R1
Akhtar, A; Bell, C; Ghali, L; Li, D; Wang, SX; Wen, X1

Reviews

1 review(s) available for arsenic trioxide and folic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for arsenic trioxide and folic acid

ArticleYear
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Folic acid or combination of folic acid and vitamin B(12) prevents short-term arsenic trioxide-induced systemic and mitochondrial dysfunction and DNA damage.
    Environmental toxicology, 2009, Volume: 24, Issue:4

    Topics: Animals; Antioxidants; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Biomarkers; Catalase; Chemoprevention; Dehydroascorbic Acid; DNA Damage; Drug Therapy, Combination; Folic Acid; Glutathione; Islets of Langerhans; Lymphocytes; Male; Mitochondria; Nitrites; Oxidative Stress; Oxides; Rats; Superoxide Dismutase; Vitamin B 12

2009
Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
    Molecular cancer therapeutics, 2009, Volume: 8, Issue:7

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Drug Carriers; Drug Delivery Systems; Female; Flow Cytometry; Folic Acid; Humans; Liposomes; Nanoparticles; Nasopharyngeal Neoplasms; Oxides; Tumor Cells, Cultured

2009
Microbial synthesis of poly-3-hydroxybutyrate and its application as targeted drug delivery vehicle.
    Bioresource technology, 2013, Volume: 145

    Topics: Animals; Arsenic Trioxide; Arsenicals; Bacillus; Cell Line, Tumor; Drug Delivery Systems; Folate Receptor 1; Folic Acid; Hydroxybutyrates; Mice; Nanoparticles; Oxides; Particle Size; Polyesters; Polyvinyl Alcohol

2013
Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.
    International journal of molecular sciences, 2019, Apr-30, Volume: 20, Issue:9

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Female; Folic Acid; HeLa Cells; Humans; Liposomes; Papillomaviridae; Polyethylene Glycols; Uterine Cervical Neoplasms

2019